ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression

MLA

Chen Xue, et al. “ALYREF Mediates RNA M5C Modification to Promote Hepatocellular Carcinoma Progression.” Signal Transduction and Targeted Therapy, vol. 8, no. 1, Mar. 2023, pp. 1–3. EBSCOhost, https://doi.org/10.1038/s41392-023-01395-7.

APA

Chen Xue, Xinyu Gu, Qiuxian Zheng, Qingmiao Shi, Xin Yuan, Yuanshuai Su, Junjun Jia, Jianwen Jiang, Juan Lu, & Lanjuan Li. (2023). ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression. Signal Transduction and Targeted Therapy, 8(1), 1–3. https://doi.org/10.1038/s41392-023-01395-7

Chicago

Chen Xue, Xinyu Gu, Qiuxian Zheng, Qingmiao Shi, Xin Yuan, Yuanshuai Su, Junjun Jia, Jianwen Jiang, Juan Lu, and Lanjuan Li. 2023. “ALYREF Mediates RNA M5C Modification to Promote Hepatocellular Carcinoma Progression.” Signal Transduction and Targeted Therapy 8 (1): 1–3. doi:10.1038/s41392-023-01395-7.